Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CardlyticsCDLX +1.67%30 12-1 Month Momentum % is -65.44% as of Aug. 13, 2026. GuruFocus rates CDLX with a GF Score™ of 30/100 and a GF Value™ of $14.54 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,014 Media - Diversified companies, Cardlytics ranks worse than 92.7% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-13), Cardlytics's 12-1 Month Momentum % is -65.44%.
The industry rank for Cardlytics's 12-1 Month Momentum % or its related term are showing as below:
CDLX's 12-1 Month Momentum % is ranked worse than 92.7% of 1014
companies
in the Media - Diversified industry
Industry Median: -17.5
vs CDLX: -65.44
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Cardlytics 12-1 Month Momentum % Related Terms
CDLX vs WIMI, MOBQ, ACCS: 12-1 Month Momentum % Comparison
For the Advertising Agencies subindustry, Cardlytics's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardlytics 12-1 Month Momentum % vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Cardlytics's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Cardlytics's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -65.44% mean?
Cardlytics (CDLX) has a 12-1 Month Momentum % of -65.44% as of Aug. 13, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Cardlytics and its competitors. According to the industry distribution chart, Cardlytics ranks #940 out of 1014 companies in the Media - Diversified industry, placing it in the top 92.7%.
Is Cardlytics' 12-1 Month Momentum % too high?
Cardlytics' current 12-1 Month Momentum % is -65.44%. Based on the distribution chart, Cardlytics ranks #940 out of 1014 companies in the Media - Diversified industry, which is in the bottom quartile relative to peers. Overall, Cardlytics has a GF Score™ of 30/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cardlytics' 12-1 Month Momentum % compare to WIMI and MOBQ?
According to the Media - Diversified industry distribution chart, Cardlytics ranks #940 out of 1014 companies for 12-1 Month Momentum %. This places Cardlytics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Media - Diversified company?
A good 12-1 Month Momentum % depends on the Media - Diversified industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Cardlytics and its competitors. Cardlytics's current 12-1 Month Momentum % is -65.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardlytics stock overvalued right now?
Based on GuruFocus' analysis, Cardlytics (CDLX) is currently considered Possible Value Trap. The stock's GF Value™ is $14.54, compared to a current price of $4.26 — trading 70.7% below its estimated fair value. The current 12-1 Month Momentum % is -65.44%. Cardlytics' overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Cardlytics (CDLX), the current 12-1 Month Momentum % is -65.44% as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardlytics (CDLX) Overvalued in 2026?
Based on GuruFocus' analysis, Cardlytics stock appears to be undervalued.
The current stock price of $4.26 is trading 70.7% below its estimated GF Value™ of $14.54.
GuruFocus considers Cardlytics to be Possible Value Trap.
Key valuation signals for CDLX:
12-1 Month Momentum %: -65.44%
GF Value™: $14.54 vs. price of $4.26 (70.7% below fair value)
No single metric tells the full story. See the CDLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.
30GF Score
Get the complete analysis for CDLX
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CDLX has been successfully added to your 
